Quarterly Activities Report and Appendix 4C

Open PDF
Stock Clearvue Technologies Ltd (CPV.ASX)
Release Time 30 Jan 2025, 10:18 a.m.
Price Sensitive Yes
 ClearVue secures top tier partners in Middle East, China and UK
Key Points
  • Expands partnership with Alutec and Aria Holdings to distribute ClearVue's solar glass products in the UAE
  • Signs new OEM Manufacturing Agreement with Maxblue Industrial Glass in China for five years
  • Signs new Manufacturing and Distribution Licence Agreement with My Glass Projects in the UK
Full Summary

ClearVue Technologies Limited (ASX:CPV; OTC:CVUEF) has provided its quarterly activities report and Appendix 4C for the period ending 31 December 2024 (Q2 FY25). The company has secured new licensees for the manufacture and distribution of ClearVue products in several regions, including expanding its partnership with Alutec and Aria Holdings to distribute its solar glass products in the United Arab Emirates, signing a new OEM Manufacturing Agreement with Maxblue Industrial Glass in China for five years, and signing a new Manufacturing and Distribution Licence Agreement with My Glass Projects in the United Kingdom. These partnerships are a key part of ClearVue's business model, allowing it to leverage its licensees' established markets and manufacturing capabilities to accelerate the commercialization of its products. The company has also acquired the IP and assets of ROOTS Sustainable Agricultural Technologies, enabling it to integrate ROOTS' ag-tech solutions with its solar greenhouse and solar glazing products, expanding its offering in the ag-tech market. ClearVue has strengthened its presence in the US market, won the Hong Kong Green Tech Challenge, and continues to make progress on its research and development initiatives.

Guidance

ClearVue expects to receive an R&D rebate of $1.1 million during the March 2025 quarter.

Outlook

ClearVue enters the second half of FY25 with important partnerships in North America, Europe, Asia Pacific, and Africa, positioning the company to accelerate commercialization as its partnerships deliver their first sales, complementing its direct sales efforts. The company's work with leading research institutions will continue, and it expects trial data to show the positive impact its technology has on greenhouse crops, strengthening its position as a leader in ag-tech solutions.